88 related articles for article (PubMed ID: 18224686)
1. Designing antibodies for the inhibition of gastrin activity in tumoral cell lines.
Barderas R; Shochat S; Timmerman P; Hollestelle MJ; Martínez-Torrecuadrada JL; Höppener JW; Altschuh D; Meloen R; Casal JI
Int J Cancer; 2008 May; 122(10):2351-9. PubMed ID: 18224686
[TBL] [Abstract][Full Text] [Related]
2. Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation.
Martínez-Torrecuadrada J; Cifuentes G; López-Serra P; Saenz P; Martínez A; Casal JI
Clin Cancer Res; 2005 Sep; 11(17):6280-90. PubMed ID: 16144932
[TBL] [Abstract][Full Text] [Related]
3. Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology.
Tohidkia MR; Asadi F; Barar J; Omidi Y
BioDrugs; 2013 Feb; 27(1):55-67. PubMed ID: 23344946
[TBL] [Abstract][Full Text] [Related]
4. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer.
Watson SA; Michaeli D; Grimes S; Morris TM; Robinson G; Varro A; Justin TA; Hardcastle JD
Cancer Res; 1996 Feb; 56(4):880-5. PubMed ID: 8631028
[TBL] [Abstract][Full Text] [Related]
5. [Blocking the gastrin/cholecystokinin-B receptor autocrine loop influences the growth and apoptosis of human gastric cancer cells].
Wang WL; Zhou JJ; Zhou XC; Yang XF
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1989-92. PubMed ID: 17064598
[TBL] [Abstract][Full Text] [Related]
6. Development of XPA067.06, a potent high affinity human anti-gastrin monoclonal antibody.
Hsu SJ; Patel A; Larsen PD; Bohmann DJ; Bauer RJ; Ma JK; Masat L; Roell M; Babuka SJ; Hansen RK; White M; Haak-Frendscho M
Biochem Pharmacol; 2008 Aug; 76(3):340-52. PubMed ID: 18589401
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II study of G17-DT, an anti-gastrin immunogen, in advanced colorectal cancer.
Smith AM; Justin T; Michaeli D; Watson SA
Clin Cancer Res; 2000 Dec; 6(12):4719-24. PubMed ID: 11156225
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines.
Hoosein NM; Kiener PA; Curry RC; Rovati LC; McGilbra DK; Brattain MG
Cancer Res; 1988 Dec; 48(24 Pt 1):7179-83. PubMed ID: 3191491
[TBL] [Abstract][Full Text] [Related]
9. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide.
Hoosein NM; Kiener PA; Curry RC; Brattain MG
Exp Cell Res; 1990 Jan; 186(1):15-21. PubMed ID: 2298233
[TBL] [Abstract][Full Text] [Related]
10. Phage antibody library screening for the selection of novel high-affinity human single-chain variable fragment against gastrin receptor: an in silico and in vitro study.
Jalilzadeh-Razin S; Mantegi M; Tohidkia MR; Pazhang Y; Pourseif MM; Barar J; Omidi Y
Daru; 2019 Jun; 27(1):21-34. PubMed ID: 30607886
[TBL] [Abstract][Full Text] [Related]
11. The CCK-2/gastrin splice variant receptor retaining intron 4 transactivates the COX-2 promoter in vitro.
Huang H; Ansorge N; Schrader H; Banasch M; Yu HG; Schmidt WE; Höcker M; Schmitz F
Regul Pept; 2007 Dec; 144(1-3):34-42. PubMed ID: 17936921
[TBL] [Abstract][Full Text] [Related]
12. Screening and identification of recombinant anti-idiotype antibodies against gastric cancer and colon cancer monoclonal antibodies by a phage-displayed single-chain variable fragment library.
Zhikui L; Changcun G; Yongzhan N; Fengtian H; Xingling R; Shujun L; Zheyi H; Ying H; Xin W; Daiming F
J Biomol Screen; 2010 Mar; 15(3):308-13. PubMed ID: 20150588
[TBL] [Abstract][Full Text] [Related]
13. [Expression of gastrin in human gastric cancer cell line and effect of anti-gastrin mAb on the cell growth].
Wang X; Wei DP; Cai MY
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):276-8. PubMed ID: 15996318
[TBL] [Abstract][Full Text] [Related]
14. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
15. Antibodies raised by gastrimmune inhibit the spontaneous metastasis of a human colorectal tumour, AP5LV.
Watson SA; Michaeli D; Morris TM; Clarke P; Varro A; Griffin N; Smith A; Justin T; Hardcastle JD
Eur J Cancer; 1999 Aug; 35(8):1286-91. PubMed ID: 10615243
[TBL] [Abstract][Full Text] [Related]
16. Targeting of cholecystokinin B/gastrin receptor in colonic, pancreatic and hepatocellular carcinoma cell lines.
Savage K; Waller HA; Stubbs M; Khan K; Watson SA; Clarke PA; Grimes S; Michaeli D; Dhillon AP; Caplin ME
Int J Oncol; 2006 Dec; 29(6):1429-35. PubMed ID: 17088981
[TBL] [Abstract][Full Text] [Related]
17. Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor.
Watson SA; Clarke PA; Morris TM; Caplin ME
Cancer Res; 2000 Oct; 60(20):5902-7. PubMed ID: 11059789
[TBL] [Abstract][Full Text] [Related]
18. [A study of gastrin-focal adhesion kinase signal pathway in human colon cancer cells].
Ding J; Yu JP; Li D; Luo HS; Yu HG
Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):434-7. PubMed ID: 16008856
[TBL] [Abstract][Full Text] [Related]
19. G17DT--a new weapon in the therapeutic armoury for gastrointestinal malignancy.
Watson SA; Gilliam AD
Expert Opin Biol Ther; 2001 Mar; 1(2):309-17. PubMed ID: 11727538
[TBL] [Abstract][Full Text] [Related]
20. Phage display selection of fully human antibody fragments to inhibit growth-promoting effects of glycine-extended gastrin 17 on human colorectal cancer cells.
Khajeh S; Tohidkia MR; Aghanejad A; Mehdipour T; Fathi F; Omidi Y
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1082-1090. PubMed ID: 29886758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
